hiddenheader
Web Content Viewer (JSR 286)
Customized coverage backed by 100 years of business insurance expertise

INFORMATION ABOUT CNA

Share this content via email or social networks

21st Century Cures Act Will Exacerbate Pharmaceutical Risk

Modern medicine and biotechnology accomplish amazing feats with cutting edge technology, but they are confronting complex and changing regulations.

"Onco-Immunotherapy, CRISPR, Cybernetic Implants, Regenerative Medicine, Gene Therapy, Robotics – many of these recent life sciences breakthroughs sound like science fiction.

"But they are very real. And the impact of discoveries such as these could redefine what it means to be human.

"Although these advancements are being realized through the most cutting-edge science, the greatest risk associated with marketing these products remains one of the oldest challenges.

"Regulations."

 

Read more in "The 21st Century Cures Act Will Exacerbate Life Sciences Pharmaceutical Risk," from the Insights section of Risk & Insurance.

Facebook
Twitter
LinkedIn
Email